EUVIMEDEUVIMED entdecken
Open Access

Predictable regulation of survival by intratumoral microbe-immune crosstalk in patients with lung adenocarcinoma

Shuo Shi, Yuwen Chu, Haiyan Liu, Lan Yu, Dejun Sun, Jialiang Yang, Geng Tian, Lei Ji, Cong Zhang, Xinxin Lu

Microbial Cell · 2024 · 11 · 29-40

DOI: 10.15698/mic2024.02.813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Cell, 2024. Verfasst von Shuo Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intratumoral microbiota can regulate the tumor immune microenvironment (TIME) and mediate tumor prognosis by promoting inflammatory response or inhibiting anti-tumor effects. Recent studies have elucidated the potential role of local tumor microbiota in the development and progression of lung adenocarcinoma (LUAD). However, whether intratumoral microbes are involved in the TIME that mediates the prognosis of LUAD remains unknown. Here, we obtained the matched tumor microbiome and host transcriptome and survival data of 478 patients with LUAD in The Cancer Genome Atlas (TCGA). Machine learning models based on immune cell marker genes can predict 1- to 5-year survival with relative accuracy. Patients were stratified into high- and low-survival-risk groups based on immune cell marker genes, with significant differences in intratumoral microbial communities. Specifically, patients in the high-risk group had significantly higher alpha diversity (p < 0.05) and were characterized by an enrichment of lung cancer-related genera such as Streptococcus. However, network analysis highlighted a more active pattern of dominant bacteria and immune cell crosstalk in TIME in the low-risk group compared to the high-risk group. Our study demonstrated that intratumoral microbiota-immune crosstalk was strongly associated with prognosis in LUAD patients, which would provide new targets for the development of precise therapeutic strategies.

Schlagwörter

Stichwörter der Autor:innen

immune cellintratumoral microbiotalung adenocarcinomaprognosistumor microenvironment

Autor:innen und Institutionen

  • The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China.
  • Geneis Beijing Co., Ltd., Beijing 100102, China.
  • Qingdao Geneis Institute of Big Data Mining and Precision Medicine, Qingdao 266000, Shandong, China.
  • College of Information Engineering, Changsha Medical University, Changsha 410219, Hunan, China.
  • Academician Workstation, Changsha Medical University, Changsha 410219, Hunan, China.
  • Clinical Medical Research Center, Inner Mongolian People's Hospital, No. 20, Zhaowuda Road, Hohhot, Inner Mongolia, China.

Zitieren

APA

Shi, S., Chu, Y., Liu, H., Yu, L., Sun, D., Yang, J., Tian, G., Ji, L., Zhang, C., & Lu, X. (2024). Predictable regulation of survival by intratumoral microbe-immune crosstalk in patients with lung adenocarcinoma. Microbial Cell, 11, 29-40. https://doi.org/10.15698/mic2024.02.813

Vancouver

Shi S, Chu Y, Liu H, Yu L, Sun D, Yang J, et al. Predictable regulation of survival by intratumoral microbe-immune crosstalk in patients with lung adenocarcinoma. Microbial Cell. 2024;11:29-40. doi:10.15698/mic2024.02.813

BibTeX
@article{Shi2024,
  author = {Shi, Shuo and Chu, Yuwen and Liu, Haiyan and Yu, Lan and Sun, Dejun and Yang, Jialiang and Tian, Geng and Ji, Lei and Zhang, Cong and Lu, Xinxin},
  title = {Predictable regulation of survival by intratumoral microbe-immune crosstalk in patients with lung adenocarcinoma},
  journal = {Microbial Cell},
  year = {2024},
  volume = {11},
  pages = {29--40},
  doi = {10.15698/mic2024.02.813}
}
Kostenlos starten →